Marianne holds a bachelor’s degree in pharmacology and a post graduate diploma in microbiology and immunology. She moved from industrial pharmacy to market research in 2012 and found her passion in oncology. The rapidly evolving oncology landscape fascinates her, fulfils her thirst for knowledge and it fills her with hope to see better outcomes offered to patients every day. Marianne specialises in solid tumours and has also worked across multiple haematological malignancies. ASCO and ESMO weeks are her best weeks of the year.

Having joined HRW in 2009, and leveraging a degree in history that leaned heavily into story driven communication, a career in market research seemed like the perfect fit for Kirsty. With the launch of OR:BIT in 2016, she was enthusiastic to join the team and take the opportunity to develop an academic interest in the complex and evolving science of the Oncology space. Kirsty’s particular passion lies in patient research, and having the opportunity to get close to a multitude of different patients, to learn about their experiences and hear first-hand about their challenges and hopes surrounding living with, or dying from, cancer is inspirational. Her core areas of specialism include NSCLC, myeloma, head and neck, prostate and haematological malignancies such as AML, CML and CLL.

Sophie developed her interest in oncology during her MSci in biochemistry, in particular studying cancer immunotherapies. She joined HRW in 2016, pursuing her interest in oncology and discovering a passion for patient research. Sophie has expertise across multiple solid tumour and haematological cancers, ranging from the most common types to rare cancers, and is always looking for new opportunities to connect with cancer patients.

Liz came into market research with a background in strategic communication and a graduate degree in Advertising, where her research focused on activating health behavior changes in underserved populations. She been involved in oncology market research for the past decade, supporting brand development at various stages of their life cycle from foundational journey and launch, through expanding indications & portfolio strategy, all the way through patent extension. A seasoned moderator, Liz has led & conducted thousands of interviews with patients, caregivers, physicians, nurses, and other key stakeholders. She has wide-ranging experience with immune-oncology agents & targeted therapies across a range of solid tumors, in both metastatic and adjuvant settings. In particular, Liz has enjoyed her work in breast cancer, urothelial carcinoma, and developing pan-tumor strategy.

With a background in psychology and business, Alex loves putting her curiosity to work exploring human behavior to build strong brands. She fell in love with the pharma industry from the start but knew she was home when she did her first oncology project over a decade ago. Since then, she’s focused heavily on Oncology, specializing in solid tumors with a particular interest in targeted therapies and rare malignancies. Alex loves exploring the complex realities of those living with and treating cancer in order to help her clients empathize and navigate this space as they bring live changing solutions to market.

Jessica joined HRW in 2022 after completing her MSc in Cognitive and Clinical Neuroscience from Brunel University London. Throughout her degree, she worked as a research assistant where she a focused her research on attention and perception which are immensely important parts of human psychology. She has also always had an immense passion for oncology research and frequently takes part in the Cancer Research UK London Winter Run every year to show her support. After join HRW, she very quickly learnt there was an opportunity to grow her knowledge and passion in oncology research and hopes to bring her science expertise to the team.

Oliver joined HRW in 2022 after completing an MSc in Health Behaviour Change from UCL. His background is in customer insights and behavioural science, having worked with clients across healthcare, higher education and the third sector for over a decade. After joining HRW, he quickly specialised in oncology research with physicians, patients and payers across a broad range of tumour types and indications. This expertise gives Ollie a robust understanding of the oncology landscape to leverage when thinking about behavioural drivers critical to meeting your strategic needs.